Fig A2.
Correlation between induction in peripheral blood mononuclear cell (PBMC) histone acetylation with plasma vascular endothelial growth factor (VEGF) levels in patients with renal cell carcinoma. Correlation between fold increase in PBMC histone acetylation and ratio of post-treatment to pretreatment plasma VEGF levels among patients with renal cell carcinoma (Pearson’s r = −0.59; P = .01).